Written by Timothy Aungst, PharmD | Reviewed by Joshua Murdock, PharmDPublished on February 21, 2022 Key takeaways: The FDA approved 93 first-time generics in the U.S. in 2021. This is compared to 72 first-time generics approved in 2020. Most of these first-time generics were focused on health conditions like autoimmune disorders, heart disease, and diabetes....
Key takeaways: The FDA approved 72 new first-time generic drugs in 2020. Several important brand-name drugs that went generic in 2020 include Daraprim, Teclfidera, Finacea, Glucagon, Pradaxa, and Flovent HFA. During 2021, we may see generic approvals for Truvada, Bystolic, and Brilinta. The FDA’s Center for Drug Evaluation and Research (CDER) is responsible for evaluating...
